HopeStage
Back to all studies
CompletedNCT00188942

Brain activity during depression in bipolarity and major depression

About this title

A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder

Read the official source — NCT00188942
Medication studyAges 18–55Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
Toronto and 1 more locationSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateFebruary 2005
Recruitment status
Completed
Enrollment listed in the registry
42
Sponsor
University Health Network, Toronto
Sponsor type
University
Study type
Drug
Intervention type
Drug, Procedure
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Canada
Age range
From 18 Years to 55 Years
Official registry ID
NCT00188942
Official title
Show the full official title

Neural Correlates of Emotional Processing in Depressed and Remitted Bipolar and Unipolar Depressed Subjects: An fMRI Investigation

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Health Network, Toronto, a university.

Did this study involve medication?

Yes. The study involved medication, including Fluoxetine+Olanzapine and Olanzapine.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies